secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enliven Therapeutics, Inc. (ELVN)
CIK:        0001672619
Form:       8-K
Filed at:   2022-07-29T23:59:59+00:00
Accession:  0001564590-22-027108
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imara terminates Boston office lease early; pays $315k fee to reduce costs while exploring strategic alternatives
--------------------------------------------------------------------------------

- Terminated 9,236 sq ft office lease set to expire March 2027; termination contingent on landlord finding a new tenant.
- Paid one-time termination fee of $315,000; Landlord may draw $175k existing letter of credit plus $140k cash.
- Early termination intended to reduce operating expenses amid ongoing comprehensive strategic review to maximize stockholder value.
- If no new lease executed within 30 days, or landlord terminates, agreement is void and partial termination fee returned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672619/000156459022027108/0001564590-22-027108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672619/000156459022027108/imra-8k_20220725.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-027108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer